✦ LIBER ✦

Daclizumab: outcome of phase III trials and mechanism of action

✍ Scribed by F Vincenti; B Nashan; S Light

Book ID: 117236412
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 199 KB
Volume: 30
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(98)00571-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanism of action of new Alzheimer's t

Mechanism of action of new Alzheimer's therapeutic in phase III clinical trials

✍ Mullan, Michael; Bachmeier, Corbin; Ait-Ghezala, Ghania; Beaulieu-Abdelahad, Dav 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Clinical Trials || Mechanisms of Action,

Clinical Trials || Mechanisms of Action, Part III – Immune Disorders

✍ Brody, Tom 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 291 KB

*Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines* is a practical guidebook for those engaged in clinical trial design. This book details the organizations and content of clinical trials, including trial design, safety, endpoints, subgroups, HRQoL, con

P79 Outcome research in angina pectoris:

P79 Outcome research in angina pectoris: Limitations of some phase III trials

✍ Sylvie Ahn; Michel F. Rousseau; Hubert Pouleur 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Dynamics of mechanical actions of materi

Dynamics of mechanical actions of materials III. Vibration mechanical and electromagnetic actions

✍ M. S. Koval'chenko 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 380 KB

Denosumab: mechanism of action and clini

Denosumab: mechanism of action and clinical outcomes

✍ D. A. Hanley; J. D. Adachi; A. Bell; V. Brown 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

Indications and outcomes of AneuRx Phase

Indications and outcomes of AneuRx Phase III trial versus use of commercial AneuRx stent graft

✍ Ayerdi, Juan; McLafferty, Robert B.; Markwell, Steve J.; Solis, Maurice M.; Parr 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 58 KB